FI963227A0 - Mikrojauhettua nebivololia sisältäviä koostumuksia - Google Patents

Mikrojauhettua nebivololia sisältäviä koostumuksia

Info

Publication number
FI963227A0
FI963227A0 FI963227A FI963227A FI963227A0 FI 963227 A0 FI963227 A0 FI 963227A0 FI 963227 A FI963227 A FI 963227A FI 963227 A FI963227 A FI 963227A FI 963227 A0 FI963227 A0 FI 963227A0
Authority
FI
Finland
Prior art keywords
pct
compositions containing
containing micronized
micronized nebivolol
sec
Prior art date
Application number
FI963227A
Other languages
English (en)
Swedish (sv)
Other versions
FI117888B (fi
FI963227A (fi
Inventor
Eugeen Marie Jozef Jans
Guido Franciscus Smans
Paul Marie Victor Gilis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22731545&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI963227(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI963227A0 publication Critical patent/FI963227A0/fi
Publication of FI963227A publication Critical patent/FI963227A/fi
Application granted granted Critical
Publication of FI117888B publication Critical patent/FI117888B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Dental Preparations (AREA)
FI963227A 1994-02-17 1996-08-16 Mikrojauhettua nebivololia sisältäviä koostumuksia FI117888B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19798894A 1994-02-17 1994-02-17
US19798894 1994-02-17
EP9500489 1995-02-10
PCT/EP1995/000489 WO1995022325A1 (en) 1994-02-17 1995-02-10 Compositions containing micronized nebivolol

Publications (3)

Publication Number Publication Date
FI963227A0 true FI963227A0 (fi) 1996-08-16
FI963227A FI963227A (fi) 1996-08-16
FI117888B FI117888B (fi) 2007-04-13

Family

ID=22731545

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963227A FI117888B (fi) 1994-02-17 1996-08-16 Mikrojauhettua nebivololia sisältäviä koostumuksia

Country Status (30)

Country Link
US (1) US5759580A (fi)
EP (1) EP0744946B1 (fi)
JP (1) JP3810079B2 (fi)
KR (1) KR100361636B1 (fi)
CN (1) CN1112921C (fi)
AT (1) ATE212547T1 (fi)
AU (1) AU688860B2 (fi)
BR (1) BR9506828A (fi)
CA (1) CA2182582C (fi)
CY (1) CY2329B1 (fi)
CZ (1) CZ290844B6 (fi)
DE (1) DE69525241T2 (fi)
DK (1) DK0744946T3 (fi)
ES (1) ES2171533T3 (fi)
FI (1) FI117888B (fi)
HU (1) HU221848B1 (fi)
IL (1) IL112659A (fi)
MX (1) MX9603314A (fi)
MY (1) MY115339A (fi)
NO (1) NO314712B1 (fi)
NZ (1) NZ279822A (fi)
PL (1) PL178505B1 (fi)
PT (1) PT744946E (fi)
RU (1) RU2137473C1 (fi)
SG (1) SG47487A1 (fi)
SI (1) SI0744946T1 (fi)
SK (1) SK283250B6 (fi)
TW (1) TW355683B (fi)
WO (1) WO1995022325A1 (fi)
ZA (1) ZA951294B (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT801564E (pt) * 1994-12-28 2002-09-30 Janssen Pharmaceutica Nv Utilizacao de nebivolol como agente anti-aterogernico
SK283370B6 (sk) 1995-12-27 2003-06-03 Janssen Pharmaceutica N. V. Bioadhezívna farmaceutická kompozícia a spôsob jej prípravy
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
DE69728179T2 (de) * 1997-06-13 2004-11-25 Nanodel Technologies Gmbh System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
US20030152636A1 (en) * 2000-02-23 2003-08-14 Nanopharm Ag Method of treating cancer
US6531158B1 (en) * 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
WO2002087508A2 (en) 2001-05-02 2002-11-07 Nitromed, Inc. Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
US7803838B2 (en) * 2004-06-04 2010-09-28 Forest Laboratories Holdings Limited Compositions comprising nebivolol
CN101006081B (zh) 2004-07-30 2011-02-09 托伦特药物有限公司 奈必洛尔及其药学可接受盐、制备方法以及奈必洛尔的药物组合物
DE602004026789D1 (de) * 2004-08-11 2010-06-02 Hetero Drugs Ltd Neues verfahren zur herstellung von nebivololzwischenprodukten
US7344907B2 (en) * 2004-11-19 2008-03-18 International Business Machines Corporation Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
AP2764A (en) * 2005-01-31 2013-09-30 Mylan Lab Inc Hydroxylated nebivolol metabolites
EP1850842A1 (de) * 2005-02-11 2007-11-07 Stada Arzneimittel Ag Pharmazeutische zusammensetzungen nebivolo und ein hydrophiles polymer
US7560575B2 (en) * 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
EP1803716B1 (en) * 2005-12-28 2012-07-25 Acino Pharma AG A process for preparation of racemic nebivolol
EP1973895A1 (en) * 2006-01-18 2008-10-01 Hetero Drugs Limited Process for isolation of desired isomers of nebivolol intermediates
EP1839658A1 (en) * 2006-03-30 2007-10-03 Hexal A/S Pharmaceutical composition comprising micronized nebivolol
DE102006036579A1 (de) * 2006-08-04 2008-02-07 Alfred E. Tiefenbacher Gmbh & Co.Kg Pharmazeutische Zusammensetzung
ATE462415T1 (de) * 2006-08-04 2010-04-15 Alfred E Tiefenbacher Gmbh & C Pharmazeutische zusammensetzung enthaltend nebivolol
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
EP2124931A4 (en) * 2007-01-22 2013-08-28 Mylan Pharmaceuticals Ulc PHARMACEUTICAL COMPOSITIONS COMPRISING NEBIVOLOL OR AN ANALOGUE OF NEBIVOLOL
US20100172972A1 (en) * 2007-05-21 2010-07-08 Sun Pharmaceutical Industries Limited Enteric coated pharmaceutical compositions
US20090030071A1 (en) * 2007-07-26 2009-01-29 Shaw Andrew A Treatment of Cardiovascular Disease in Mexican Americans Using Nebivolol
CN101463024B (zh) 2007-12-21 2011-06-08 上海现代制药股份有限公司 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法
WO2009091777A1 (en) * 2008-01-15 2009-07-23 Forest Laboratories Holdings Limited Nebivolol in the treatment of sexual dysfunction
ATE533752T1 (de) 2008-09-08 2011-12-15 Cadila Pharmaceuticals Ltd Verbesserter herstellungsprozess für nebivolol- hydrocholorid
IT1395354B1 (it) 2009-07-23 2012-09-14 Zach System Spa Processo di preparazione di nebivololo
IT1397962B1 (it) 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
KR20110130872A (ko) * 2010-05-28 2011-12-06 현대약품 주식회사 결정형 염산 네비볼롤을 포함하는 약학 조성물 및 제조방법
CN102985077A (zh) * 2010-07-02 2013-03-20 Fmc有限公司 固体形式
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法
CN117503775A (zh) * 2017-04-28 2024-02-06 自由生物有限公司 治疗特应性皮炎以及提高活性药物成分稳定性的制剂、方法、试剂盒和剂型
US20220016025A1 (en) * 2020-07-08 2022-01-20 Vinayak Dinesh DENDUKURI Formulations of nebivolol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60107106A (ja) * 1983-11-15 1985-06-12 Mitsubishi Electric Corp 曲線補間装置
CA1337429C (en) * 1983-12-05 1995-10-24 Guy Rosalia Eugene Van Lommen Derivatives of 2,2'-iminobisethanol
CA1337432C (en) * 1988-03-23 1995-10-24 Raymond M. Xhonneux Method of lowering the blood pressure
JPH02264744A (ja) * 1989-04-04 1990-10-29 Kyowa Hakko Kogyo Co Ltd 光学活性なｐ―フルオロフェノキシ誘導体およびその製造法

Also Published As

Publication number Publication date
ATE212547T1 (de) 2002-02-15
FI117888B (fi) 2007-04-13
JPH09508913A (ja) 1997-09-09
SK283250B6 (sk) 2003-04-01
CA2182582C (en) 2005-03-29
SI0744946T1 (en) 2002-06-30
CZ290844B6 (cs) 2002-10-16
PT744946E (pt) 2002-07-31
HU9602272D0 (en) 1996-10-28
IL112659A0 (en) 1995-05-26
DE69525241D1 (de) 2002-03-14
AU688860B2 (en) 1998-03-19
MY115339A (en) 2003-05-31
PL178505B1 (pl) 2000-05-31
AU1706895A (en) 1995-09-04
NZ279822A (en) 1997-04-24
CY2329B1 (en) 2004-02-06
CA2182582A1 (en) 1995-08-24
US5759580A (en) 1998-06-02
EP0744946B1 (en) 2002-01-30
NO314712B1 (no) 2003-05-12
SG47487A1 (en) 1998-04-17
HUT75332A (en) 1997-05-28
SK105896A3 (en) 1997-05-07
JP3810079B2 (ja) 2006-08-16
CZ234696A3 (en) 1996-11-13
DK0744946T3 (da) 2002-05-06
ES2171533T3 (es) 2002-09-16
HU221848B1 (hu) 2003-02-28
BR9506828A (pt) 1997-09-30
IL112659A (en) 1999-06-20
DE69525241T2 (de) 2002-08-29
MX9603314A (es) 1997-02-28
CN1140991A (zh) 1997-01-22
KR100361636B1 (ko) 2003-02-11
CN1112921C (zh) 2003-07-02
PL315973A1 (en) 1996-12-23
NO963439L (no) 1996-08-16
TW355683B (en) 1999-04-11
FI963227A (fi) 1996-08-16
RU2137473C1 (ru) 1999-09-20
ZA951294B (en) 1996-08-16
WO1995022325A1 (en) 1995-08-24
EP0744946A1 (en) 1996-12-04

Similar Documents

Publication Publication Date Title
PT744946E (pt) Composicoes contendo nebivolol micronizado
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
DE69522947T2 (de) Phenylxanthin-derivate
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
FI962323A (fi) N-substituoidut atsabisykloheptaanijohdannaiset, kuten esim. neuroleptit
DK0646110T3 (da) N-substituerede 3-azabicyclo(3.2.0) heptanderivater som neuroleptika
NO307376B1 (no) N-substituerte azabicykloheptan-derivater egnet som neuroleptika
IL107520A0 (en) Substituted ortho-ethenylphenylacetic acid derivatives and pharmaceutical compositions containing them
NO950177D0 (no) Farmakologisk aktive erivater

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117888

Country of ref document: FI

MA Patent expired